Sign in Sign Up Free

Perceptive Advisors LLC

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

261

Stocks Covered

104

Latest Filing

Jan 22, 2026

Filings

Orchestra BioMed Holdings, Inc.

SC 13G/A · Jul 17, 2024

12.8%

4.6M shares

Biodesix, Inc.

SC 13G · May 13, 2024

5.6%

6.7M shares

Contineum Therapeutics, Inc.

SC 13G · Apr 15, 2024

8.5%

1.6M shares

Acrivon Therapeutics, Inc.

SC 13G/A · Apr 15, 2024

17.4%

5.4M shares

Precision Biosciences, Inc.

SC 13G · Mar 14, 2024

7.9%

500K shares

Artivion, Inc.

SC 13G · Mar 11, 2024

5.8%

2.4M shares

Relmada Therapeutics, Inc.

SC 13G/A · Mar 6, 2024

0.0%

0 shares

Iovance Biotherapeutics, Inc.

SC 13G · Mar 2, 2024

6.9%

19.2M shares

enVVeno Medical Corporation

SC 13G/A · Feb 23, 2024

9.9%

1.4M shares

Rain Oncology Inc.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

Forte Biosciences, Inc.

SC 13G/A · Feb 14, 2024

9.9%

3.6M shares

Applied Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

5.9%

4.6M shares

Aldeyra Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

14.6%

8.6M shares

Inhibrx, Inc.

SC 13G/A · Feb 14, 2024

9.9%

4.8M shares

Bellerophon Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

ADMA Biologics, Inc.

SC 13G/A · Feb 14, 2024

2.8%

6.4M shares

Orchestra BioMed Holdings, Inc.

SC 13G/A · Feb 14, 2024

6.8%

2.4M shares

Arcellx, Inc.

SC 13G/A · Feb 14, 2024

8.8%

4.5M shares

Verrica Pharmaceuticals Inc.

SC 13G/A · Feb 14, 2024

16.9%

7.1M shares

Larimar Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

CymaBay Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

3.5%

4.0M shares

Zymeworks Inc.

SC 13G/A · Feb 14, 2024

1.5%

1.1M shares

RAPT Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

6.2%

2.1M shares

CARGO Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

8.3%

3.4M shares

Leap Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

4.0%

1.1M shares

enVVeno Medical Corporation

SC 13G/A · Feb 14, 2024

9.9%

1.4M shares

Amicus Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

9.6%

28.1M shares

Amylyx Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2024

2.8%

1.9M shares

Acrivon Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

13.6%

3.0M shares

Celcuity Inc.

SC 13G/A · Feb 14, 2024

6.1%

1.5M shares

Veru Inc.

SC 13G/A · Feb 14, 2024

3.8%

5.6M shares

Evolus, Inc.

SC 13G/A · Feb 14, 2024

6.9%

4.0M shares

Iovance Biotherapeutics, Inc.

SC 13G/A · Feb 14, 2024

4.7%

12.0M shares

Verona Pharma plc

SC 13G/A · Feb 14, 2024

4.8%

3.9M shares

Spyre Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

7.2%

2.6M shares

Rhythm Pharmaceuticals, Inc.

SC 13G · Feb 12, 2024

5.5%

3.3M shares

Viridian Therapeutics, Inc.

SC 13G · Jan 29, 2024

6.7%

4.0M shares

Fusion Pharmaceuticals Inc.

SC 13G · Jan 19, 2024

6.5%

4.7M shares

Solid Biosciences Inc.

SC 13D/A · Jan 12, 2024

18.6%

6.9M shares

Nuvalent, Inc.

SC 13G · Jan 2, 2024

5.1%

2.9M shares

Athira Pharma, Inc.

SC 13D/A · Dec 29, 2023

14.2%

5.4M shares

Celcuity Inc.

SC 13G · Dec 26, 2023

5.7%

1.4M shares

Spyre Therapeutics, Inc.

SC 13G · Dec 13, 2023

7.2%

2.6M shares

Applied Therapeutics, Inc.

SC 13G · Dec 6, 2023

5.9%

4.6M shares

Evolus, Inc.

SC 13G · Nov 27, 2023

5.4%

3.1M shares

VBI Vaccines Inc.

SC 13D/A · Nov 17, 2023

5.8%

1.4M shares

Nautilus Biotechnology, Inc.

SC 13D/A · Nov 17, 2023

10.1%

12.6M shares

CARGO Therapeutics, Inc.

SC 13G · Nov 14, 2023

8.4%

3.2M shares

Aldeyra Therapeutics, Inc.

SC 13G/A · Oct 18, 2023

14.7%

8.6M shares

Orchestra BioMed Holdings, Inc.

SC 13G · Sep 13, 2023

6.8%

2.4M shares